An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)

RUBY YUN-JU HUANGWong M.K.Tan T.Z.Kuay K.T.C Ng A.H.Chung V.Y.Chu Y.-S.Matsumura N.Lai H.-C.Lee Y.F.Sim W.-J.Chai C.Pietschmann E.Mori S.Low J.J.H.Choolani M.Thiery J.P.2020-06-262020-06-2620132041-4889https://www.scopus.com/inward/record.uri?eid=2-s2.0-84889570568&doi=10.1038%2fcddis.2013.442&partnerID=40&md5=e62a4db3de6a57ac58a85fe57ebf0a73https://scholars.lib.ntu.edu.tw/handle/123456789/504747[SDGs]SDG15An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)journal article10.1038/cddis.2013.442242018142-s2.0-84889570568